These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 37315551

  • 21. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.
    Abu El-Asrar AM, Al Tamimi M, Hemachandran S, Al-Mezaine HS, Al-Muammar A, Kangave D.
    Acta Ophthalmol; 2013 Sep; 91(6):e486-93. PubMed ID: 23575246
    [Abstract] [Full Text] [Related]

  • 22. Significant prognostic factors for Vogt-Koyanagi-Harada disease in the early stage.
    Sheu SJ, Kou HK, Chen JF.
    Kaohsiung J Med Sci; 2004 Mar; 20(3):97-105. PubMed ID: 15124893
    [Abstract] [Full Text] [Related]

  • 23. [Optical coherence tomography angiography of acute Vogt-Koyanagi-Harada disease].
    Jia SS, Zhao C, Gong D, Chen Z, Zhang MF.
    Zhonghua Yan Ke Za Zhi; 2017 Oct 11; 53(10):735-739. PubMed ID: 29050185
    [Abstract] [Full Text] [Related]

  • 24. Acute lymphoblastic leukemia manifesting as acute Vogt-Koyanagi-Harada disease.
    Yang HK, Yu HG.
    Korean J Ophthalmol; 2009 Dec 11; 23(4):325-8. PubMed ID: 20046700
    [Abstract] [Full Text] [Related]

  • 25. Decrease of choriocapillary vascular density measured by optical coherence tomography angiography in Vogt-Koyanagi-Harada disease.
    Liang A, Jia S, Gao F, Han X, Pei M, Qu Y, Xiao J, Zhao C, Zhang M.
    Graefes Arch Clin Exp Ophthalmol; 2021 Nov 11; 259(11):3395-3404. PubMed ID: 34216256
    [Abstract] [Full Text] [Related]

  • 26. Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging.
    Fukutsu K, Namba K, Iwata D, Mizuuchi K, Kase S, Suzuki K, Shimizu H, Shibata Y, Yamawaki F, Onozawa M, Ishida S.
    BMC Ophthalmol; 2020 Mar 10; 20(1):94. PubMed ID: 32156266
    [Abstract] [Full Text] [Related]

  • 27. Indocyanine green angiographic findings in initial-onset acute Vogt-Koyanagi-Harada disease.
    Abouammoh MA, Gupta V, Hemachandran S, Herbort CP, Abu El-Asrar AM.
    Acta Ophthalmol; 2016 Sep 10; 94(6):573-8. PubMed ID: 26823203
    [Abstract] [Full Text] [Related]

  • 28. Recovery of macular cone photoreceptors in Vogt-Koyanagi-Harada disease.
    Nakamura T, Hayashi A, Oiwake T.
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb 10; 256(2):387-394. PubMed ID: 29264653
    [Abstract] [Full Text] [Related]

  • 29. Comparison of Clinical Features and Visual Outcome between Sympathetic Ophthalmia and Vogt-Koyanagi-Harada Disease in Chinese Patients.
    Yang P, Liu S, Zhong Z, Du L, Ye Z, Zhou W, Kijlstra A.
    Ophthalmology; 2019 Sep 10; 126(9):1297-1305. PubMed ID: 30959067
    [Abstract] [Full Text] [Related]

  • 30. Longitudinal observation of subretinal fibrosis in Vogt-Koyanagi-Harada disease.
    Zhao C, Dong F, Gao F, Liu X, Pei M, Jia S, Zhang M.
    BMC Ophthalmol; 2018 Jan 15; 18(1):6. PubMed ID: 29334924
    [Abstract] [Full Text] [Related]

  • 31. High prevalence of angle-closure glaucoma in Vogt-Koyanagi-Harada disease.
    Alvarez-Guzman C, Valdez-Garcia JE, Ruiz-Lozano RE, Rodriguez-Garcia A, Navas-Villar CF, Hartleben-Matkin C, Pedroza-Seres M.
    Int Ophthalmol; 2022 Dec 15; 42(12):3913-3921. PubMed ID: 35789316
    [Abstract] [Full Text] [Related]

  • 32. Prognostic factors for Vogt-Koyanagi-Harada disease.
    Sheu SJ, Kou HK, Chen JF.
    J Chin Med Assoc; 2003 Mar 15; 66(3):148-54. PubMed ID: 12779034
    [Abstract] [Full Text] [Related]

  • 33. Comparison of the Clinical Manifestations between Acute Vogt-Koyanagi-Harada Disease and Acute Bilateral Central Serous Chorioretinopathy.
    Shin WB, Kim MK, Lee CS, Lee SC, Kim H.
    Korean J Ophthalmol; 2015 Dec 15; 29(6):389-95. PubMed ID: 26635455
    [Abstract] [Full Text] [Related]

  • 34. Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.
    Nakai K, Gomi F, Ikuno Y, Yasuno Y, Nouchi T, Ohguro N, Nishida K.
    Graefes Arch Clin Exp Ophthalmol; 2012 Jul 15; 250(7):1089-95. PubMed ID: 22240936
    [Abstract] [Full Text] [Related]

  • 35. Effect of immunosuppressive therapy on oxygen saturation and diameter of retinal vessels in initial onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM, Alotaibi MD, Gikandi PW, Stefánsson E.
    Acta Ophthalmol; 2021 Feb 15; 99(1):75-82. PubMed ID: 32592327
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Elevated Serum Immunoglobulin E Levels are Associated with the Severity of Newly Diagnosed, Acute Vogt-Koyanagi-Harada Disease.
    Ji H, Zhang N, Zhu M, Dong J, Jiang Z.
    Curr Eye Res; 2022 Jan 15; 47(1):102-106. PubMed ID: 34264155
    [Abstract] [Full Text] [Related]

  • 39. Vitreous surgery for bilateral bullous retinal detachment in Vogt-Koyanagi-Harada syndrome.
    Gaun S, Kurimoto Y, Komurasaki Y, Yoshimura N.
    Ophthalmic Surg Lasers; 2002 Jan 15; 33(6):508-10. PubMed ID: 12449230
    [Abstract] [Full Text] [Related]

  • 40. Risk factors for subretinal fibrosis in patients with Vogt Koyanagi Harada syndrome.
    Golzarri MF, Cheja-Kalb R, Concha-Del-Río LE, Gonzalez-Salinas R, Arellanes-García L.
    Ocul Immunol Inflamm; 2022 Feb 17; 30(2):265-269. PubMed ID: 33021860
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.